The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19

Background: Similar pathogenesis makes Corona Virus Disease 2019 (COVID-19) associated with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and gouty arthritis (GA), and it is possible to introduce common drugs for the treatment of RA, AS and GA into the treatment of COVID-19. That is, “homot...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ping, Ye, Jingyao, Jia, Menglong, Li, Xiaopeng, Wei, Shujun, Li, Nianhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354910/
https://www.ncbi.nlm.nih.gov/pubmed/35935817
http://dx.doi.org/10.3389/fphar.2022.960267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354910/
https://www.ncbi.nlm.nih.gov/pubmed/35935817
http://dx.doi.org/10.3389/fphar.2022.960267

Ejemplares similares